Latest filing published 07 Jul 2014 for Furiex Pharmaceuticals, Inc..
No signal scores available.
This profile gathers the share dealings of Peter B. Corr in Furiex Pharmaceuticals, Inc. Over a trading history stretching from 24 May 2013 to 2 July 2014, the count stands at 14 filings.
On the market, this insider has only sold: 2 sales, €233k in total. Other entries cover 4 share grants and 5 option exercises.
The newest entry dates from 7 July 2014: a transaction, in Furiex Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations